The main medication used to treat von Hippel-Lindau disease is belzutifan (Welireg), a hypoxia-inducible factor inhibitor. This medication can also help treat kidney cancer. It work by inhibiting specific proteins that promote tumor growth. This medication is typically taken as oral pills.